BIO-key International, a leader in fingerprint biometric identification technologies, mobile credentialing and identity verification solutions, today reported that IBM granted validation of BIO-key’s finger biometric authentication solutions, for IBM® Security Access Manager (ISAM) for Web. ISAM for Web provides an access control management solution to centralize network and application security policy for e-business applications. The full and complete integration of BIO-key solutions within ISAM for Web was completed earlier this month and is now available for customer implementation.
IBM customers seeking solutions for two-factor authentication for e-business applications now have a validated solution from BIO-key. BIO-key’s ID Director for ISAM for Web delivers two-factor and risk based authentication for ISAM for Web utilizing our flexible, fast, and extremely accurate fingerprint authentication technology.
ISAM for Web solutions interact with a variety of client operating systems and applications. BIO-key’s interoperable and scalable fingerprint biometric technology helps ISAM for Web customers reduce the risk of fraud along with its associated costs and consequences, install lean process improvement, increase interface time, and achieve two-factor authentication in a secure and complaint manner. The company’s technology operates on any type of device including PCs, workstations, laptops, tablets, and smartphones. Additionally, BIO-key’s software is compatible with most of the major platforms and is integrated with more than forty fingerprint readers. BIO-key’s objective is to future proof the authentication process, knowing that as new devices are introduced to the market, BIO-key will continue to support them.
“We are enthused to receive our certification for the latest IBM security platform solution for Web applications. Any IBM customer utilizing ISAM can now add a biometric component for convenient multi-factor authentication to any supported application,” stated Mike DePasquale, BIO-key CEO. Considering the size of IBM’s installed base of accounts this can represent a significant opportunity for BIO-key.”
Source StockHouse.